Gammagard liquid 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FDK66
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,810
Award facts
- Contract value 100% obligated
- $17,810.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $17,810.20 by the Defense Logistics Agency on July 22, 2025, for the supply of Gammagard Liquid 10% in 200 ml vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of August 12, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Gammagard Liquid 10% is an intravenous immunoglobulin therapy used to treat various immunodeficiency disorders and other immune-related conditions within the Department of Defense healthcare system. The award demonstrates DMS Pharmaceutical Group's continued role as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status and established presence as a pharmaceutical distributor to federal agencies since 2001. The company's contract portfolio reflects specialization in delivering specialized pharmaceutical products including biologics, branded medications, and medical consumables directly to military health facilities across the United States.
Quick answers
Who was awarded contract SPE2DB25FDK66?
SPE2DB25FDK66 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FDK66 worth?
The government has obligated $17,810 on SPE2DB25FDK66.
Is contract SPE2DB25FDK66 an order under another contract?
Yes. SPE2DB25FDK66 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK66 competed?
The extent of competition for SPE2DB25FDK66 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award